Company Tagline
Nova has built jinkō, a unique in silico clinical trial simulation platform to de-risk and accelerate clinical trials
Industry Category
Business Keywords
Company Description
Nova In Silico is a leading software development company specializing in innovative solutions for the pharmaceutical and biotechnology industries. Located at 1 Place Giovanni da Verrazzano, Lyon, Rhône 69009, FR, Nova In Silico is dedicated to accelerating and de-risking clinical trials through its cutting-edge simulation platform, jinkō.
Nova In Silico's jinkō platform empowers biotech, pharma companies, academic research centers, and non-profit organizations to unlock the full potential of modeling and simulation. By predicting trial outcomes, identifying best responders, optimizing drug regimens, and generating synthetic control arms, Nova In Silico enables more efficient and successful clinical trial designs.
With a commitment to advancing the R&D of new therapies for the benefit of patients, Nova In Silico continues to drive innovation in the field of in silico clinical trials. We invite the management team at Nova In Silico to create a customized and exclusive company showcase and product listing on our platform to further highlight their exceptional work.
Nova In Silico est une entreprise de développement de logiciels de premier plan, spécialisée dans les solutions innovantes pour les industries pharmaceutiques et biotechnologiques. Située au 1 Place Giovanni da Verrazzano, Lyon, Rhône 69009, FR, Nova In Silico se consacre à l'accélération et à la réduction des risques des essais cliniques grâce à sa plateforme de simulation de pointe, jinkō.
La plateforme jinkō de Nova In Silico permet aux entreprises de biotechnologie et pharmaceutiques, aux centres de recherche universitaires et aux organisations à but non lucratif de libérer tout le potentiel de la modélisation et de la simulation. En prédisant les résultats des essais, en identifiant les meilleurs répondeurs, en optimisant les schémas posologiques et en générant des bras de contrôle synthétiques, Nova In Silico permet de concevoir des essais cliniques plus efficaces et plus réussis.
Avec un engagement à faire progresser la R&D de nouvelles thérapies au profit des patients, Nova In Silico continue de stimuler l'innovation dans le domaine des essais cliniques in silico. Nous invitons l'équipe de direction de Nova In Silico à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre davantage en valeur leur travail exceptionnel.
Key Personnel / Employees
Compare Companies Side by Side
Compare Nova In Silico with 1 companies in Software-Development
| Comparison Field |
Nova In SilicoMain Company |
Journal of Pharmacok...View Profile |
|---|---|---|
|
Founded Year
|
— | 1973 |
|
Company Size
|
— | 1 employee |
|
City
|
Lyon, Rhône | |
|
Country
|
France | |
|
Skills & Keywords
Comparing with main company
|
14 Total Skills
In Silico Clinical Trials
Software Development
Pharmaceutical R&D
Clinical Trial Simulation
Pharmacometrics
Drug Development
Biotech Innovation
Computer Sciences
Clinical pharmacology
PK/PD
In silico clinical trials
Quantitative clinical pharmacology
QSP
Systems biology
|
2 Total
2 Unique
Unique Skills:
PBPK
PKPD
|
2
Total Companies1973
Oldest Founded1
Countries16
Unique SkillsSimilar Companies
Other organizations in the same industry
Taggbox
Software-DevelopmentCollect, curate and display social media stories anywhere
CAUDIA
Software-DevelopmentAccédez à des transactions comparables pour conforter vos évaluations
Alternative Company Names
This company is also known as